C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/1993
01/02/1993	WO1993000925A1 Isolation and characterization of a novel protease from streptomyces lividans
01/02/1993	CA2090463A1 Isolation and characterization of a novel protease from streptomyces lividans
01/02/1993	CA2072475A1 In vitro maturation of denuded bovine oocytes
12/1992
12/30/1992	EP0520962A2 Plasmid vectors for gene expression in plants
12/30/1992	EP0520843A2 The acid sphingomyelinase gene and diagnosis of niemann-pick disease
12/30/1992	EP0520807A1 Method and apparatus for inducing controlled inherent stress reducing behaviour in animals.
12/30/1992	EP0520794A1 Methods for detection of carcinoma metastases by nucleic acid amplification
12/30/1992	EP0520756A2 Method for lysing mycobacteria
12/30/1992	EP0520753A1 Recombinant fowlpox vaccine for protection against Marek's disease
12/30/1992	EP0520502A2 Anti-Hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
12/30/1992	EP0520436A2 Monoclonal antibody, method of production thereof and use thereof
12/30/1992	EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor
12/30/1992	EP0520039A1 A process for distinguishing nucleic acids on the basis of nucleotide differences.
12/30/1992	EP0520029A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated.
12/30/1992	EP0520004A1 A gene expression system
12/29/1992	WO1993001286A2 Localized oligonucleotide therapy
12/29/1992	US5175385 Virus-resistant transgenic mice
12/29/1992	US5175384 For model systems to study aids
12/29/1992	US5175383 Animal model for benign prostatic disease
12/29/1992	US5175272 DNA sequences with increased expression of HBcAg
12/29/1992	US5175271 Use of silica gel for DNA extraction with organic solvents
12/29/1992	US5175268 DNA encoding recombinant human lymphotoxin
12/29/1992	US5175252 Cloned gene encoding for bacteriocin from pediococcus acidilactici
12/29/1992	US5175147 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
12/29/1992	US5175108 Compatible, stable; genetic engineering
12/29/1992	US5175107 Used as medical-use nutritive mixtures, as fodder additie of animals, chemical and pharmaceutical reagent, and growth factor for microorganisms production other amino acids such as L-lysin, L-homoerin
12/29/1992	US5175105 Process for the production of urokinase using saccharomyes cerevisiae
12/29/1992	US5175104 Gene coding for phosphotransacetylase inserted into vector dna
12/29/1992	US5175103 Preparation of pure cultures of post-mitotic human neurons
12/29/1992	US5175102 Modification of plant viruses or their effects
12/29/1992	US5175101 Recombinant restriction enzyme sau3ai
12/29/1992	US5175099 Retrovirus-mediated secretion of recombinant products
12/29/1992	US5175098 Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to HIV
12/29/1992	US5175097 Genetic engineering
12/29/1992	US5175096 Dna encoding a fibronectin binding protein as well as its preparation
12/29/1992	US5175095 Ovary-tissue transcriptional factors
12/29/1992	US5175082 Method of characterizing genomic dna
12/29/1992	US5174993 Immunology
12/29/1992	US5174986 Method for determining oncogenic potential of a chemical compound
12/29/1992	CA2082411A1 Localized oligonucleotide therapy
12/29/1992	CA2072412A1 Monoclonal antibody, method of production thereof and use thereof
12/29/1992	CA1312031C Process for the purification of serum albumin
12/29/1992	CA1312029C Method for increasing gene expression
12/29/1992	CA1312028C Expression vectors containing the heat shock regulatory dna sequences from a heat shock protein 83 (hsp83) gene and inducible expression by use of the vectors
12/29/1992	CA1312027C Methods and compositions for expression of competent eukaryotic gene products
12/29/1992	CA1312026C Plasmid vectors for efficient expression of genes in e. coli
12/29/1992	CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas
12/29/1992	CA1312024C Process for preparing hybridoma cells which produce tumour-specific monoclonal antibodies
12/28/1992	CA2091364A1 Method and primer for preparing dna
12/28/1992	CA2072246A1 Ccv vaccine
12/24/1992	DE4120213A1 Monoclonal antibodies against TNF-BP I - used for immunoassays to detect TNF-BP I in diagnosis of bacterial infection septic shock, graft versus host disease and cerebral malaria
12/24/1992	DE4120178A1 New human mitochondrial malate enzyme and DNA encoding it
12/23/1992	WO1992022671A1 Polynucleotide determination with selectable cleavage sites
12/23/1992	WO1992022665A1 Production and recovery of recombinant neurotrophins
12/23/1992	WO1992022658A1 Recombinant immunogenic actinomycetale
12/23/1992	WO1992022657A1 Antigen-enzyme conjugate expression and detection system
12/23/1992	WO1992022656A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
12/23/1992	WO1992022655A1 Hepatitis c diagnostics and vaccines
12/23/1992	WO1992022653A1 Method for making humanized antibodies
12/23/1992	WO1992022652A1 GABA-A RECEPTOR SUBUNITS (α-2, α-3, α-5, α-6, β-2) AND TRANSFECTED CELLS EXPRESSING THEM
12/23/1992	WO1992022651A1 Antisense oligonucleotide inhibition of the ras gene
12/23/1992	WO1992022650A1 Recombination-facilitated multiplex analysis of dna fragments
12/23/1992	WO1992022649A1 Use of exo-sample nucleotides in gene cloning
12/23/1992	WO1992022646A1 Production of human hemoglobin in transgenic pigs
12/23/1992	WO1992022645A1 Transgenic immunodeficient non-human animals
12/23/1992	WO1992022644A1 Production of a protein of interest in the milk of a transgenic mammelian
12/23/1992	WO1992022641A1 Immunodeficiency virus recombinant poxvirus vaccine
12/23/1992	WO1992022640A1 Rb TRANSFERRED CELLS AND METHOD
12/23/1992	WO1992022638A1 Perilipin
12/23/1992	WO1992022635A1 Targeted delivery of genes encoding secretory proteins
12/23/1992	WO1992022582A1 Novel organ-specific plant promoter sequences
12/23/1992	WO1992022579A1 MIMIC PEPTIDES OF gp120
12/23/1992	WO1992022567A1 Super glucocorticoid receptors: receptors with increased affinity and specificity for glucocorticoid steroids
12/23/1992	WO1992022333A1 Transgenic mice expressing human collagen gene
12/23/1992	WO1992022332A2 Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
12/23/1992	WO1992022327A1 Double recombinant vaccinia virus vaccines
12/23/1992	WO1992022326A1 Insertional mutations in mycobacteria
12/23/1992	WO1992022324A1 Microbially-produced antibody fragments and their conjugates
12/23/1992	WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992	WO1992022320A1 C1 inhibitor variants and treating inflammatory response with c1 inhibitor
12/23/1992	WO1992022319A1 SUBSTANTIALLY PURE RECEPTOR LIKE TGF-β1 BINDING MOLECULES AND USES THEREOF
12/23/1992	WO1992022303A1 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides
12/23/1992	WO1992017588A3 Method for production of an iga binding protein derived from group b streptococci
12/23/1992	WO1992015605A3 Inhibitors of human neutrophil elastase and human cathepsin g
12/23/1992	EP0519889A2 Leydig cell stimulator
12/23/1992	EP0519869A2 A receptor protein kinase gene encoded at the self-incompatibility locus
12/23/1992	EP0519866A1 Novel anti-HIV antibodies
12/23/1992	EP0519829A1 Cloning and/or expressionvectors, preparation and use
12/23/1992	EP0519728A2 Anti-TCF-II monoclonal antibodies and method for the measurement of TCF-II by applying the antibodies
12/23/1992	EP0519596A1 A method for reducing the immunogenicity of antibody variable domains
12/23/1992	EP0519547A2 Coccidiosis poultry vaccine
12/23/1992	EP0519469A1 Cloned glutamic acid decarboxylase
12/23/1992	EP0519463A1 Synthetic, catalytic oligonucleotides
12/23/1992	EP0519338A1 Improved methods for nucleic acid amplification
12/23/1992	EP0519336A2 Chimeric gene comprising a promoter-regulater and a gene coding for an indicator protein
12/23/1992	EP0519229A2 Alkaline protease gene from fusarium sp
12/23/1992	EP0519218A2 Hybrid-plasmid for the 38 kDa antigen from M. tuberculosis, E. coli as host, the 38 kDa antigen and a 33 kDa protein
12/23/1992	EP0519113A1 Bacterial strains having high productivity of an amino acid and method of constructing these strains
12/23/1992	EP0519053A1 Nucleic acid amplification with dna-dependent rna polymerase activity of rna replicases.
12/23/1992	EP0519039A1 HUMAN bFGF DERIVATIVES, THEIR ANALOGS AND PROCESS FOR THEIR PRODUCTION

1 ... 3863 3864 3865 3866 3867 3868 3869 3870 3871 3872 3873 3874 3875 3876 3877 3878 3879 3880 3881 3882 3883 ... 4023